HO840M3200824445
PEAK ALTAZAZZLE-ET
011HO15036
Mastitis Resistance
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK |
|---|---|---|---|---|
| 31 | 219 | 88% | 103 | 83% |
| Proof | Weighting | |
|---|---|---|
| Clinical Mastitis in First Lactation: | 105 | 33% |
| Clinical Mastitis in Later Lactations: | 101 | 33% |
| Somatic Cell Score (Combined): | 104 | 33% |
| Breed Average: | 100 |
| Clinical Mastitis in Daughters | ||
|---|---|---|
| First Lactation | Later Lactations | |
| No. Herds | 29 | 20 |
| No. Daughters | 211 | 69 |
| % Healthy Daughters | 99% | 94% |
| Breed Average | 95% | 91% |
Somatic Cell Score
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK |
|---|---|---|---|---|
| 112 | 610 | 99% | 104 | 81% |
Breed Average: 100
| First Lactation | Second Lactation | Third Lactation | |
|---|---|---|---|
| Weighting | 33% | 33% | 33% |
| Rating | 103 | 104 | 105 |
| Breed Average | 100 | 100 | 100 |
Metabolic Diseases
GEBV 26*APR| Expected % Healthy Daughters | |||||||
|---|---|---|---|---|---|---|---|
| Herds | Daughters | Reliability | Proof | %RK | 1st Lact. | Later Lact. | |
| Subclinical Ketosis | 145 | 557 | 95% | 102 | 74% | +1.0% | +1.5% |
| Clinical Ketosis | 20 | 116 | 64% | 98 | 42% | -0.7% | -0.7% |
| Displaced Abomasum | 15 | 66 | 61% | 98 | 43% | -0.9% | -0.6% |
| Metabolic Disease Resistance | 84% | 100 | 61% | ||||
Fertility Disorders
GEBV 26*APR| Expected % Healthy Daughters | |||||||
|---|---|---|---|---|---|---|---|
| Herds | Daughters | Reliability | Proof | %RK | 1st Lact. | Later Lact. | |
| Retained Placenta | 29 | 280 | 93% | 106 | 92% | +1.9% | +2.2% |
| Metritis | 14 | 109 | 93% | 106 | 96% | +2.8% | +2.1% |
| Cystic Ovaries | 11 | 52 | 92% | 101 | 61% | +0.3% | +0.6% |
Hoof Health
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK | Index Weighting | Expected % Healthy Daughters |
|---|---|---|---|---|---|---|
| 11 | 60 | 93% | 103 | 85% | ||
| Digital Dermatitis | 94% | 111 | 99% | 34% | +13.6% | |
| Interdigital Dermatitis | 80% | 96 | 35% | 9% | -1.4% | |
| Heel Horn Erosion | 92% | 91 | 16% | 14% | -4.4% | |
| Sole Ulcer | 93% | 96 | 40% | 20% | -3.5% | |
| Toe Ulcer | 92% | 100 | 40% | 10% | 0.0% | |
| White Line Lesion | 92% | 103 | 73% | 8% | +1.5% | |
| Sole Hemorrhage | 91% | 96 | 33% | 3% | -2.1% | |
| Interdigital Hyperplasia | 80% | 104 | 80% | 2% | +1.6% | |
Calf Health
GEBV 26*APR| Herds | Daughters | Reliability | Proof | %RK | Expected % Healthy Daughters | |
|---|---|---|---|---|---|---|
| Respiratory Problems | 20 | 248 | 97% | 102 | 71% | +1.7 % |
| Diarrhea | 10 | 90 | 95% | 94 | 11% | -5.2 % |
| Calf Health | 96% | 97 | 30% | |||